Omni SuperNormal India
Investing at the core of India’s century in the making—capturing the $10 trillion opportunity, demographic tailwinds, and compounding economic growth
The Opportunity & Growth Drivers
India: A $10 Tn Opportunity
Rising household affluence and formalisation are driving sustained consumption growth
Strong government capex and private investment underpin long-term expansion
Structural shift toward manufacturing and services is accelerating economic transformation
Demographic Dividend
A young and expanding workforce supports long-duration economic growth
Increasing labour force participation and productivity gains
Rising incomes are fueling domestic demand across sectors
Digital & Physical Infrastructure Buildout
India Stack (Aadhaar, UPI, ONDC) enabling scalable digital access and inclusion
Large-scale physical infrastructure push (GatiShakti, Bharatmala, Sagarmala)
Integrated infra development improving logistics efficiency and economic productivity
Global Manufacturing & Services Shift
India emerging as a key beneficiary of global supply chain realignment
China+1 strategy accelerating diversification of manufacturing bases
Expanding export opportunity across manufacturing and services sectors
Omni’s Investment Approch
We apply Omniscience’s Scientific Investing framework to identify businesses positioned to benefit from India’s structural growth across consumption, infrastructure, manufacturing, and digital transformation.
Enhance Safety
Focus on high-quality businesses with strong balance sheets, robust governance, and resilient business models across sectors benefiting from India’s long-term growth.
Enhance Quality
Capture scalable leaders and enablers across consumption, manufacturing, infrastructure, and digital ecosystems that compound alongside India’s economic expansion.
Enhance Growth
Construct portfolios that deliver safety-first alpha by combining strong fundamentals with data-driven portfolio discipline.
Why Invest in Omni SuperNormal India?
Focused exposure to India’s structural growth drivers—consumption, infrastructure, manufacturing, and digital transformation.
Diversified flexicap portfolio spanning sector leaders and key enablers of India’s economic expansion.
Portfolio construction rooted in risk management and quality filters.
Part of Omniscience’s safety-first, research-led approach to compounding wealth.
Explore Other OMNI PMS Themes
Omni Services Corp
Investing in India’s scalable service leaders.
Omni Capital Creators
Participating in India’s financialization and capital formation cycle.
Omni Energy Transition
Capturing the shift toward sustainable energy and efficiency.
Omni Rail & Mobility
Participating in India’s infrastructure and transport transformation.
Talk to Our PMS Team
Learn how Omni Industry Inc can help you participate in India’s $3 trillion manufacturing opportunity and long-term industrial growth story.
All consultations are confidential and obligation-free.
FAQS
Omni SuperNormal India is OmniScience Capital’s flagship flexi-cap equity strategy, designed as a core allocation for investors seeking long-term wealth creation. It aims to identify fundamentally strong, attractively valued businesses across market capitalisations that can benefit from India’s structural economic transformation.
The strategy invests across market capitalisations and industries, seeking opportunities arising from India’s capital expenditure cycle, manufacturing expansion, digital transformation, financialisation, formalisation, urbanisation and changing consumption patterns. Rather than investing in themes indiscriminately, it seeks companies with the business economics, competitive advantages and financial strength to translate these structural opportunities into sustainable shareholder value.
Omni SuperNormal India follows the Scientific Investing Framework, guided by the principle of “Chase Safety, Get Alpha.” It seeks to eliminate Capital Destroyers, Capital Eroders and overvalued Capital Imploders, focusing instead on Capital Multipliers: businesses with sound financials, durable competitive advantages, growth opportunities and attractive valuations. The objective is to combine business compounding with the potential upside from valuation re-rating, while maintaining a disciplined focus on avoiding permanent capital loss.
Omni SuperNormal India is intended for investors seeking a long-term core allocation to Indian equities through a diversified, actively managed flexi-cap strategy. It is suited to investors who want exposure to India’s long-term growth opportunities across market capitalisations without having to select individual sectors or market-cap segments themselves.
The minimum ticket size for Omni SuperNormal India is ₹50 lakh.
The strategy is subject to equity market risks and fluctuations in the value of its investments. Its focus on India’s economic transformation exposes it to changes in economic growth, capital expenditure, financing conditions, manufacturing, consumption, digital adoption and other developments affecting its portfolio companies. The Scientific Investing Framework seeks to mitigate these risks but cannot eliminate them or guarantee returns.